Monitoring with clinical, endoscopic, and histologic assessments is recommended to assess for treatment response and follow patients over time with maintenance therapy When evaluating and following patients with eoe, consideration should be given to assessing and controlling both the inflammatory and fibrostenotic aspects of disease. The guidelines indicate it is important for doctors to address both the inflammation and any scarring or narrowing of the esophagus when treating and monitoring patients with eoe. Researchers at children’s hospital of philadelphia (chop) identified a potential new therapeutic target for eosinophilic esophagitis (eoe), a chronic allergic inflammatory disease of the esophagus The findings were published today in the journal gut Eoe is characterized by esophageal epithelial remodeling, barrier dysfunction and inflammation.
Researchers at children's hospital of philadelphia (chop) identified a potential new therapeutic target for eosinophilic esophagitis (eoe), a chronic allergic inflammatory disease of the esophagus. Continuation of effective dietary or pharmacologic therapy for eoe is recommended to prevent recurrence of symptoms, histologic inflammation, and endoscopic abnormalities 6fed = 6 food elimination diet eoe = eosinophilic esophagitis gerd = gastroesophageal reflux disease eos/hpf = eosinophils per high power field According to the 2024 espghan guidelines [8], esophageal biopsy remains the cornerstone for the diagnosis of eosinophilic esophagitis (eoe) The diagnosis should be considered in the presence of symptoms of esophageal dysfunction unresponsive to proton pump inhibitor (ppi) therapy.
OPEN
